These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35335891)

  • 1. Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy.
    Wang Y; Zhang R; Tang L; Yang L
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA-based therapies: Preclinical and clinical applications.
    Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
    Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy.
    Jolly KJ; Zhang F
    Adv Pharmacol; 2024; 100():247-288. PubMed ID: 39034054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
    Kwon S; Kwon M; Im S; Lee K; Lee H
    Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
    Neill B; Romero AR; Fenton OS
    ACS Appl Bio Mater; 2024 Aug; 7(8):4894-4913. PubMed ID: 37930174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic modified messenger RNA for therapeutic applications.
    Gao M; Zhang Q; Feng XH; Liu J
    Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA-Based Therapeutics in Cancer Treatment.
    Sun H; Zhang Y; Wang G; Yang W; Xu Y
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery.
    Żak MM; Zangi L
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere J; Dewitte H; De Smedt SC; Remaut K
    Drug Discov Today; 2016 Jan; 21(1):11-25. PubMed ID: 26210957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
    Kang DD; Li H; Dong Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
    Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
    Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA-based therapeutics--developing a new class of drugs.
    Sahin U; Karikó K; Türeci Ö
    Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA vaccines for cancer immunotherapy.
    Vishweshwaraiah YL; Dokholyan NV
    Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
    Malla R; Srilatha M; Farran B; Nagaraju GP
    Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses.
    Kutikuppala LVS; Kourampi I; Kanagala RSD; Bhattacharjee P; Boppana SH
    Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines.
    Alfagih IM; Aldosari B; AlQuadeib B; Almurshedi A; Alfagih MM
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33396817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
    Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.